Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN

International Archives of Allergy and Immunology

Volumn 144, Issue 4, 2007, Pages 315-324

  Kim, Yang Soon ^a   Kim, Younghwa ^a   Lee, Kang Jin ^a   Kwon, Hyung Joo ^b   Kim, Doo Sik ^c   Kim, Tae Yoon ^a,d  

^a The Catholic University of Korea   (South Korea)

^b Hallym University   (South Korea)

^c Yonsei University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Atopic dermatitis; CpG oligodeoxynucleotides; NC Nga mice; Th1 Th2 balance; Topical application

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CPG PHOSPHODIESTER OLIGODEOXYNUCLEOTIDE; CPG PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; EPIDERMIS; IMMUNE RESPONSE; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-ALLERGIC AGENTS; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DNA; FLUORESCEINS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MICE; OLIGODEOXYRIBONUCLEOTIDES; RNA, MESSENGER; SKIN; SKIN ABSORPTION;

EID: 36249032041     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106458     Document Type: Article

References (36)

1. Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M: Development of atopic dermatitislike skin lesions in STAT6-deficient NC/Nga mice. J Immunol 2002;168:2020-2027.
2. Heishi M, Imai Y, Katayama H, Hashida R, Ito M, Shinagawa A, Sugita Y: Gene expression analysis of atopic dermatitis-like skin lesions induced in NC/Nga mice by mite antigen stimulation under specific pathogen-free conditions. Int Arch Allergy Immunol 2003;132:355-363.
3. Nakazawa M, Sugi N, Kawaguchi H, Ishii N, Nakajima H, Minami M: Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 1997;99:673-682.
4. Rudikoff D, Lebwohl M: Atopic dermatitis. Lancet 1998;351:1715-1721.
5. Akdis CA, Akdis M, Simon D, Dibbert B, Weber M, Gratzl S, Kreyden O, Disch R, Wuthrich B, Blaser K, Simon HU: T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999;113:628-634.
6. Akdis CA, Akdis M, Trautmann A, Blaser K: Immune regulation in atopic dermatitis. Curr Opin Immunol 2000;12:641-646.
7. Wollenberg A, Bieber T: Atopic dermatitis: from the genes to skin lesions. Allergy 2000;55:205-213.
8. Reinhold U, Pawelec G, Wehrmann W, Herold M, Wernet P, Kreysel HW: Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferon-gamma and neopterin in patients with severe atopic dermatitis. Int Arch Allergy Appl Immunol 1988;87:120-126.
9. Sasakawa T, Higashi Y, Sakuma S, Hirayama Y, Sasakawa Y, Ohkubo Y, Goto T, Matsumoto M, Matsuda H: Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC/Nga mice. Int Arch Allergy Immunol 2001;126:239-247.
10. Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002;20:709-760.
11. Krieg AM: CpG motifs: the active ingredient in bacterial extracts? Nat Med 2003;9:831-835.
12. Verthelyi D, Klinman DM: Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates. Clin Immunol 2003;109:64-71.
13. Kwon HJ, Lee KW, Yu SH, Han JH, Kim DS: NF-kappaB-dependent regulation of tumor necrosis factor-alpha gene expression by CpG-oligodeoxynucleotides. Biochem Biophys Res Commun 2003;311:129-138.
14. Lee KW, Kim DS, Kwon HJ: CG sequence-and phosphorothioate backbone modification-dependent activation of the NF-kappaB-responsive gene expression by CpG-oligodeoxynucleotides in human RPMI 8226 B cells. Mol Immunol 2004;41:955-964.
15. Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y: Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice. J Control Release 2005;108:294-305.
16. von Beust BR, Johansen P, Smith KA, Bot A, Storni T, Kundig TM: Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. Eur J Immunol 2005;35:1869-1876.
17. Lenert P, Brummel R, Field EH, Ashman RF: TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol 2005;25:29-40.
18. Anders HJ: A Toll for lupus. Lupus 2005;14:417-422.
19. Vestergaard C, Yoneyama H, Matsushima K: The NC/Nga mouse: a model for atopic dermatitis. Mol Med Today 2000;6:209-210.
20. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C: Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-466.
21. Suto H, Matsuda H, Mitsuishi K, Hira K, Uchida T, Unno T, Ogawa H, Ra C: NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 1999;120(suppl 1):70-75.
22. Biggs JS, Buttfield IH: Radioactive indium is not readily transferred to the amniotic fluid. Aust N Z J Obstet Gynaecol 1973;13:163-164.
23. Kitagi K, Jain VV, Businga TR, Hussain I, Kline JN: Immunomodulatory effects of CpG Oligodeoxynucleotides on established Th2 responses. Clin Diagn Lab Immunol 2002;9:1260-1269.
24. Ricci M: IL-4: a key cytokine in atopy. Clin Exp Allergy 1994;24:801-812.
25. Horsmanheimo L, Harvima IT, Jarvikallio A, Harvima RJ, Naukkarinen A, Horsmanheimo M: Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994;131:348-353.
26. Broide D, Schwarze J, Tighe H, Gifford T, Nguyen MD, Malek S, Van Uden J, Martin-Orozco E, Gelfand EW, Raz E: Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 1998;161:7054-7062.
27. Ikeda RK, Miller M, Nayar J, Walker L, Cho JY, McElwain K, McElwain S, Raz E, Broide DH: Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J Immunol 2003;171:4860-4867.
28. Schwartz DA, Wohlford-Lenane CL, Quinn TJ, Krieg AM: Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J Immunol 1999;163:224-231.
29. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Rocken M, Wagner H, Heeg K: CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol 1998;160:3627-3630.
30. Grewe M, Walther S, Gyufko K, Czech W, Schopf E, Krutmann J: Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995;105:407-410.
31. Habu Y, Seki S, Takayama E, Ohkawa T, Koike Y, Ami K, Majima T, Hiraide H: The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis. J Immunol 2001;166:5439-5447.
32. Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T: Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2001;107:519-525.
33. Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J: A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998;19:359-361.
34. Grewe M, Gyufko K, Schopf E, Krutmann J: Lesional expression of interferon-gamma in atopic eczema. Lancet 1994;343:25-26.
35. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, Irimura T, Mizutani H, Matsushima K: Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999;104:1097-1105.
36. Peng Z, Wang H, Mao X, HayGlass KT, Simons FE: CpG oligodeoxynucleotide vaccination suppresses IgE induction but may fail to down-regulate ongoing IgE responses in mice. Int Immunol 2001;13:3-11.